Repository logo
Log In
  1. Home
  2. Unibas
  3. Publications
  4. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
 
  • Details

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

Date Issued
2019-01-01
Author(s)
Visvanathan, Kala
Fabian, Carol J.
Bantug, Elissa
Brewster, Abenaa M.
Davidson, Nancy E.
DeCensi, Andrea
Floyd, Justin D.
Garber, Judy E.
Hofstatter, Erin W.
Khan, Seema A.
Katapodi, Maria C.  
Pruthi, Sandhya
Raab, Rachal
Runowicz, Carolyn D.
Somerfield, Mark R.
DOI
10.1200/jco.19.01472
Abstract
To update the ASCO guideline on pharmacologic interventions for breast cancer risk reduction and provide guidance on clinical issues that arise when deciding to use endocrine therapy for breast cancer risk reduction.; An Expert Panel conducted targeted systematic literature reviews to identify new studies.; A randomized clinical trial that evaluated the use of anastrozole for reduction of estrogen receptor-positive breast cancers in postmenopausal women at increased risk of developing breast cancer provided the predominant basis for the update.; In postmenopausal women at increased risk, the choice of endocrine therapy now includes anastrozole (1 mg/day) in addition to exemestane (25 mg/day), raloxifene (60 mg/day), or tamoxifen (20 mg/day). The decision regarding choice of endocrine therapy should take into consideration age, baseline comorbidities, and adverse effect profiles. Clinicians should not prescribe anastrozole, exemestane, or raloxifene for breast cancer risk reduction to premenopausal women. Tamoxifen 20 mg/day for 5 years is still considered standard of care for risk reduction in premenopausal women who are at least 35 years old and have completed childbearing. Data on low-dose tamoxifen as an alternative to the standard dose for both pre- and postmenopausal women with intraepithelial neoplasia are discussed in the Clinical Considerations section of this article. Additional information is available at www.asco.org/breast-cancer-guidelines.
File(s)
Loading...
Thumbnail Image
Name

jco.19.01472.pdf

Size

729.56 KB

Format

Adobe PDF

Checksum

(MD5):42a60cc91f9da4dd7203daf2bf91a1f3

University of Basel

edoc
Open Access Repository University of Basel

  • About edoc
  • About Open Access at the University of Basel
  • edoc Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement